Endotelix
Plan-les-ouates
About Endotelix
Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome including diagnostic tests and treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $254.2K
- Funding stage: Seed
- Last round: Debt Financing (Mar 2023)
- Website: endotelix.com
- Phone: +41 (0) 76 335 14 91
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/endotelix-193717 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.